Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Debt to Equity (2021 - 2024)

Biofrontera has reported Debt to Equity over the past 4 years, most recently at $0.03 for Q2 2024.

  • For Q2 2024, Debt to Equity changed N/A year-over-year to $0.03; the TTM value through Jun 2024 reached $0.03, changed N/A, while the annual FY2023 figure was $0.81, 180.17% up from the prior year.
  • Debt to Equity for Q2 2024 was $0.03 at Biofrontera, up from -$0.43 in the prior quarter.
  • Over five years, Debt to Equity peaked at $6.95 in Q3 2023 and troughed at -$0.43 in Q1 2024.
  • A 4-year average of $1.06 and a median of $0.29 in 2021 define the central range for Debt to Equity.
  • Biggest five-year swings in Debt to Equity: skyrocketed 4741.7% in 2023 and later plummeted 203.58% in 2024.
  • Year by year, Debt to Equity stood at $0.29 in 2021, then increased by 1.67% to $0.29 in 2022, then surged by 180.17% to $0.81 in 2023, then tumbled by 96.67% to $0.03 in 2024.
  • Business Quant data shows Debt to Equity for BFRI at $0.03 in Q2 2024, -$0.43 in Q1 2024, and $0.81 in Q4 2023.